XML 32 R24.htm IDEA: XBRL DOCUMENT v3.24.3

ACCRUED LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2024

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consisted of the following as of September 30, 2024 and December 31, 2023:

		SEPTEMBER 30,				DECEMBER 31,
(In thousands)		2024				2023
CRO and clinical trial costs		$	19,392			$	23,541
Manufacturing activities			12,326				14,629
Professional legal and accounting fees			751				556
Interest payable			853				768
Other			3,167				814
		$	36,489			$	40,308

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration